<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Gilead Sciences enters drug agreement with Tibotec Pharmaceuticals]]></title><link>http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/</guid><comments>http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/gild/" rel="tag">Gilead Sciences (GILD)</a></p><img hspace="4" align="right" vspace="4" alt="" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/11/gild-gilead-sciences-logo.jpg" />Yesterday, <a href="http://finance.aol.com/quotes/gilead-sciences-inc/gild/nas">Gilead Sciences</a> (NASDAQ: <a href="http://finance.aol.com/quotes/gilead-sciences-inc/gild/nas">GILD</a>) announced that it <a href="http://money.aol.com/rtn/pr/gilead-sciences-announces-agreement-with-tibotec-pharmaceuticals-to-develop-and-commercialize-new-fixed-dose-combination-of-truvadaand-x00ae-and-tmc278/rfid232691710?channel=pf">entered a license and collaboration agreement</a> with Tibotec Pharmaceuticals. The two firms will combine to develop and commercialize a new once-daily, fixed-dose treatment for HIV. GILD's CEO John Martin noted, "Gilead and Tibotec share a strong focus on bringing safe and effective treatment options to people living with HIV/AIDS." <br /><br />If the collaboration is approved, GILD will assume the lead in manufacturing, registration, distribution, and commercialization of a fixed-dose combination of Truvada and rilpivirine. GILD will not be responsible for the commercialization of this combination in the developing world and Japan, which will be handled by Tibotec. The two companies will work toward an agreement to market the combination in the developing world. <p><a href="http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/" rel="bookmark">Continue reading <em>Gilead Sciences enters drug agreement with Tibotec Pharmaceuticals</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/">Gilead Sciences enters drug agreement with Tibotec Pharmaceuticals</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 17 Jul 2009 12:20:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19101820/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2009/07/17/gilead-sciences-enters-drug-agreement-with-tibotec-pharmaceutica/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>AIDS</category><category>AIDS treatment</category><category>AidsTreatment</category><category>gild</category><category>gilead sciences</category><category>GileadSciences</category><category>HIV</category><category>inthenews</category><category>pharmaceuticals</category><category>Tibotec</category><dc:creator><![CDATA[Mark Fightmaster]]></dc:creator><pubDate>Fri, 17 Jul 2009 12:20:00 EST</pubDate></item><item><title><![CDATA[DailyFinance today: AIDS rate in DC rivals African nations, defending Jim Cramer, industrial production falls and IMF's reserves double]]></title><link>http://www.bloggingstocks.com/2009/03/16/dailyfinance-today-aids-rate-in-dc-rivals-african-nations-defe/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2009/03/16/dailyfinance-today-aids-rate-in-dc-rivals-african-nations-defe/</guid><comments>http://www.bloggingstocks.com/2009/03/16/dailyfinance-today-aids-rate-in-dc-rivals-african-nations-defe/#comments</comments><description><![CDATA[<table cellspacing="0" cellpadding="5" style="border-width: 0pt;">
    <tbody>
        <tr>
            <td valign="top" align="left"><a href="http://www.dailyfinance.com/2009/03/16/the-high-price-of-ignorance-aids-rate-in-washington-dc-rivals-s/"><img vspace="4" hspace="4" border="1" alt="" src="http://www.blogcdn.com/www.dailyfinance.com/media/2009/03/government-200c111207_thumbnail.jpg" /></a></td>
            <td><a href="http://www.dailyfinance.com/2009/03/16/the-high-price-of-ignorance-aids-rate-in-washington-dc-rivals-s/">The high price of ignorance: AIDS rate in Washington DC rivals some African nations</a> </td>
        </tr>
        <tr>
            <td valign="top" align="left"><a href="http://www.dailyfinance.com/2009/03/16/defending-jim-cramer-dont-take-entertainers-too-seriously/"><img vspace="4" hspace="4" border="1" alt="" src="http://www.blogcdn.com/www.dailyfinance.com/media/2009/03/mad_money200_thumbnail.jpg" /></a></td>
            <td><a href="http://www.dailyfinance.com/2009/03/16/defending-jim-cramer-dont-take-entertainers-too-seriously/" rel="bookmark">Defending Jim Cramer: Don't take entertainers too seriously</a> </td>
        </tr>
        <tr>
            <td valign="top" align="left"><a href="http://www.dailyfinance.com/2009/03/16/u-s-industrial-production-falls-again-mirroring-global-slump/"><img vspace="4" hspace="4" border="1" alt="" src="http://www.blogcdn.com/www.dailyfinance.com/media/2009/03/careers-auto-engineer-200mk062507_thumbnail.jpg" /></a></td>
            <td> <a href="http://www.dailyfinance.com/2009/03/16/u-s-industrial-production-falls-again-mirroring-global-slump/" rel="bookmark">Industrial production falls again amid global slump</a> </td>
        </tr>
        <tr>
            <td valign="top" align="right">
            <div align="right"><a href="http://www.dailyfinance.com/2009/03/16/g-20-doubles-imfs-reserves-and-so-far-the-markets-like-it/"><img vspace="4" hspace="4" border="1" src="http://www.blogcdn.com/www.dailyfinance.com/media/2009/03/londonsummit_thumbnail.jpg" alt="" /></a></div>
            </td>
            <td> <a href="http://www.dailyfinance.com/2009/03/16/g-20-doubles-imfs-reserves-and-so-far-the-markets-like-it/">G-20 doubles IMF's reserves, and the markets like it</a> </td>
        </tr>
    </tbody>
</table><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2009/03/16/dailyfinance-today-aids-rate-in-dc-rivals-african-nations-defe/">DailyFinance today: AIDS rate in DC rivals African nations, defending Jim Cramer, industrial production falls and IMF's reserves double</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Mon, 16 Mar 2009 18:45:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2009/03/16/dailyfinance-today-aids-rate-in-dc-rivals-african-nations-defe/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1489839/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2009/03/16/dailyfinance-today-aids-rate-in-dc-rivals-african-nations-defe/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>aids</category><category>dailyfinance</category><category>g-20</category><category>industrial production</category><category>IndustrialProduction</category><category>jim cramer</category><category>JimCramer</category><dc:creator><![CDATA[Tobias Buckell]]></dc:creator><pubDate>Mon, 16 Mar 2009 18:45:00 EST</pubDate></item><item><title><![CDATA[Motorola seeing "RED"]]></title><link>http://www.bloggingstocks.com/2006/10/16/motorola-seeing-red/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2006/10/16/motorola-seeing-red/</guid><comments>http://www.bloggingstocks.com/2006/10/16/motorola-seeing-red/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/earnings-reports/" rel="tag">Earnings Reports</a>, <a href="http://www.bloggingstocks.com/category/good-news/" rel="tag">Good news</a>, <a href="http://www.bloggingstocks.com/category/products-and-services/" rel="tag">Products and Services</a>, <a href="http://www.bloggingstocks.com/category/launches/" rel="tag">Launches</a>, <a href="http://www.bloggingstocks.com/category/law/" rel="tag">Law</a>, <a href="http://www.bloggingstocks.com/category/consumer-experience/" rel="tag">Consumer Experience</a>, <a href="http://www.bloggingstocks.com/category/competitive-strategy/" rel="tag">Competitive Strategy</a>, <a href="http://www.bloggingstocks.com/category/mot/" rel="tag">Motorola (MOT)</a></p><p>Motorola Inc. (NYSE: MOT) has joined the <a href="http://today.reuters.com/news/articlehybrid.aspx?type=comktNews&amp;rpc=33&amp;storyid=2006-10-14T000438Z_01_N13388086_RTRIDST_0_LIFE-BONO-AIDS-UPDATE-1.XML">"RED" campaign to fight AIDS in Africa</a>. Created by U2's Bono, the campaign began in Britain and has moved to the U.S. in time for the December holiday shopping season. Motorola will donate a portion of the proceeds from sales of special RED cell phones to the Global Fund to Fight AIDS. Motorola joins with American Express, Gap, Nike, and other companies in this hybrid type of corporate philanthropy.</p>
<p>Motorola has partnered with Deutsche <a href="http://money.aol.com/news/articles/_a/motorola-t-mobile-venture-funds-invest/n20061009153009990001">Telekom to invest in Ruckus Wireless, Inc.</a>, which makes "smart" Wi-Fi routers capable of beaming live TV and radio into and around the home. Ruckus makes the MediaFlex router that plugs into a box set on top the TV, much like a cable TV box. Using Internet Protocol TV, IPTV, the router can beam the signal to a Wi-Fi laptop or desktop computer in that room or even in another room. Motorola is betting the ability to beam the signal throughout a home or office without adding additional wiring will prove popular with consumers. The current Ruckus MediaFlex router retails for $159.</p>
<p><a href="http://money.aol.com/news/articles/_a/motorola-iradior-debuts-public-radio/n20061009103009990002">Motorola also rolled out its iRadio deal</a> with National Public Radio (NPR) to provide leading public radio programming to radios in cars and homes, but now also to Motorola mobile phones. Motorola's iRadio offers over 600 channels of commercial-free audio programming.</p>
<p>Not all is going well with Motorola. In September, Motorola agreed to buy barcode scanner maker Symbol Technologies, Inc. (NYSE: SBL) for $15 per share, for a total of nearly $4 billion. Some <a href="http://money.aol.com/news/articles/_a/motorola-buyout-of-symbol-hit-by-suits/n20061006111909990010">Symbol Technologies shareholders have filed suit</a> seeking to stop Motorola's acquisition of Symbol. In part, the shareholders think the price per share should be higher than $15. Symbol Technologies management says the suit is without merit. It wants the acquisition to go through.</p>
<p>Interested investors will want to <a href="http://ccbn.aol.com/company.asp?client=aol&amp;ticker=MOT">listen</a> to Motorola's Q3 earnings call on Tuesday 17 October, beginning at 5:00 p.m. ET.</p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2006/10/16/motorola-seeing-red/">Motorola seeing "RED"</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Mon, 16 Oct 2006 14:13:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href=http://today.reuters.com/news/articlehybrid.aspx?type=comktNews&amp;rpc=33&amp;storyid=2006-10-14T000438Z_01_N13388086_RTRIDST_0_LIFE-BONO-AIDS-UPDATE-1.XML>Read</a>&nbsp;|&nbsp;<a href=http://money.aol.com/news/articles/_a/motorola-t-mobile-venture-funds-invest/n20061009153009990001>Read</a>&nbsp;|&nbsp;<a href=http://money.aol.com/news/articles/_a/motorola-iradior-debuts-public-radio/n20061009103009990002>Read</a>&nbsp;|&nbsp;<a href=http://money.aol.com/news/articles/_a/motorola-buyout-of-symbol-hit-by-suits/n20061006111909990010>Read</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2006/10/16/motorola-seeing-red/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/685671/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2006/10/16/motorola-seeing-red/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>Afirca</category><category>AIDS</category><category>Motorola</category><category>National Public Radio</category><category>NationalPublicRadio</category><category>Symbol Technologies</category><category>SymbolTechnologies</category><category>U2 Bono</category><category>U2Bono</category><category>wireless communications</category><category>WirelessCommunications</category><dc:creator><![CDATA[Victoria Erhart]]></dc:creator><pubDate>Mon, 16 Oct 2006 14:13:00 EST</pubDate></item></channel></rss>
